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Abstract. 
 
We have identiﬁed a novel, highly conserved
protein of 14 kD copurifying with late endosomes/lyso-
somes on density gradients. The protein, now termed p14,
is peripherally associated with the cytoplasmic face of late
endosomes/lysosomes in a variety of different cell types.
 
In a two-hybrid screen with p14 as a bait, we identi-
ﬁed the mitogen-activated protein kinase (MAPK)
scaffolding protein MAPK/extracellular signal–regu-
lated kinase (ERK) kinase (MEK) partner 1 (MP1) as
an interacting protein. We conﬁrmed the speciﬁcity of
 
this interaction in vitro
 
 
 
by glutathione 
 
S
 
-transferase
 
pull-down assays and by coimmunoprecipitation, co-
sedimentation on glycerol gradients, and colocalization.
Moreover, expression of a plasma membrane–targeted
p14 causes mislocalization of coexpressed MP1. In ad-
dition, we could reconstitute protein complexes con-
taining the p14–MP1 complex associated with ERK
and MEK in vitro.
The interaction between p14 and MP1 suggests a
 
MAPK scaffolding activity localized to the cytoplas-
mic surface of late endosomes/lysosomes, thereby com-
bining catalytic scaffolding and subcellular compart-
mentalization as means to modulate MAPK signaling
within a cell.
Key words: signal transduction scaffold • MEK •
ERK • subcellular localization • endocytosis
 
Introduction
 
One of the challenges in cell biology is to identify the se-
quence of events following the activation of a signaling re-
ceptor. A large number of proteins involved in signal
transduction have been identified, and several of these
have been shown to be organized into transducing mod-
ules (for example, the mitogen-activated protein kinase
 
[MAPK]
 
1
 
 module). However, the majority of receptors
use only a limited number of modules. The key question is
how the cell is able to orchestrate these modules in a way
that allows specific signals to be translated into receptor-
specific responses.
Membrane traffic helps to maintain the subcellular loca-
tion of proteins and lipids. Within a cell, there are two sepa-
rate major trafficking pathways, the secretory and the en-
docytic pathway, although both systems are interconnected.
Intracellular trafficking plays a major role in signal trans-
duction mainly because after ligand binding, most signaling
receptors are endocytosed. For a long time, it was thought
that the major impact of endocytosis on signaling is by
downregulating the number of surface receptors (Di Fiore
and Gill, 1999). Using dominant negative dynamin in EGF-
activated cells, it became clear that the EGF receptor
(EGFR) activates its targets Ras, Raf, and MAPK/extra-
cellular signal–regulated kinase (ERK) kinase (MEK) at
the plasma membrane. But endocytosis has to occur to acti-
vate the MAPK ERK (Kranenburg et al., 1999). Of addi-
tional interest in this context is that members of this growth
factor family that differ in their intracellular fates also differ
in their signaling properties. ErbB1 for instance is routed
for lysosomal degradation only when induced by EGF but
 
recycles when binding TGF-
 
a
 
. In contrast, ErbB3, whose
ligands are the neuregulins, is always recycled (Baulida et
al., 1996). Another receptor for which membrane traffic has
 
J
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been shown to be important is protease-activated receptor
(PAR)2, a member of the PAR family of G protein–cou-
pled receptors. Endocytosis of activated PAR2 is necessary
for the activated receptor to meet its downstream effectors
Raf and ERK on the endocytic compartment. By this, acti-
vated ERK is sequestered and kept away from entering the
nucleus, thereby achieving substrate selectivity (DeFea et
al., 2000). These functional studies together with localiza-
tion data detecting members of the MAPK module on en-
docytic structures (Pol et al., 1998; Kranenburg et al., 1999)
emphasized the importance of endocytosis as regulator of
signal transduction (Ceresa and Schmid, 2000).
Within epithelial cells, an additional level of complexity
is added to the organizational skills of a cell. Apical–basal
polarity separates the epithelial cell into two distinct do-
mains. Correct sorting of receptors and downstream effec-
tors is crucial for proper flow of information (Kuwada et
al., 1998; Hobert et al., 1999). Disturbance of this organi-
zation leads to pathophysiological consequences like in-
creased autocrine stimulation of EGFR in cyst epithelia in
polycystic kidney disease (Wilson, 1997) and crypt epithe-
lia of colon carcinoma (Tong et al., 1998) or ablation of an
EGFR-dependent, vulva-inducing signal in 
 
Caenorhabdi-
tis elegans
 
 (Kaech et al., 1998; Whitfield et al., 1999).
Another important concept emerging during very recent
years aims to explain how an activated enzyme selects the
appropriate substrates by scaffolding (Pawson and Scott,
1997; Whitmarsh and Davis, 1998). Several proteins have
been identified that influence signaling by routing certain
partners of a cascade together in one complex. The cellu-
lar repertoire of such molecules spans from organizers of
giant “transducisomes” like inaD to simple trimeric com-
plex builders like MEK partner 1 (MP1). Their role in sig-
nal transduction is thought to enhance specificity and se-
lectivity by bringing together components of a given
pathway and separating them from other upstream activa-
tors as well as from downstream targets (anchoring scaf-
folds) or bringing the selected partners in close proximity
(catalytic scaffolds) (Burack and Shaw, 2000).
To better understand how a cell organizes spatiotempo-
ral patterns of signal-transducing elements, it will be nec-
essary to analyze protein complexes that are formed on
and/or recruited to intracellular membranes upon signal-
ing. An important question in this respect is whether
scaffolding occurs on intracellular membranes. We ap-
proached this question by analyzing the proteomes of
endocytic organelles by a combination of subcellular frac-
tionation, two-dimensional gel electrophoresis (2DGE),
and microsequencing.
In this report, we describe the identification of a hith-
erto uncharacterized protein. It localizes to late endo-
somes/lysosomes where it interacts with the MAPK scaf-
fold MP1 (Schaeffer et al., 1998). Both proteins can be
found in complex with elements of the MAPK module,
raising the possibility that the MAPK ERK1 is recruited to
and activated on late endosomes/lysosomes.
 
Materials and Methods
 
Cells and Tissue Culture
 
EpH4 murine mammary epithelial cells (Fialka et al., 1996), Caco-2 cells,
and HeLa cells were grown in high glucose DME supplemented with 10
mM Hepes, pH 7.3, 50 IU/ml penicillin, 50 
 
m
 
g/ml streptomycin, and 5%
 
FCS at 37
 
8
 
C, in 5% CO
 
2
 
 and 98% humidity. Media and reagents for tissue
culture were purchased from GIBCO BRL (Life Technologies), and FCS
was obtained from BioWhittaker (Boehringer).
 
Antibodies
 
Polyclonal anti-p14 antiserum was raised against a glutathione 
 
S
 
-trans-
ferase (GST) fusion protein of p14. Anti-MP1 antibodies were raised
against the peptide Kp532 (CVSDRDGVPVIKVANDSAPEHALR,
amino acids 24–46, mouse MP1, sequence data available from GenBank/
EMBL/DDBJ under accession no. AF082526) and affinity purified on
Affi-Gel matrix (Bio-Rad Laboratories) according to the manufacturer’s
instructions. Polyclonal antibodies recognizing the myc epitope were ob-
tained from Gramsch Laboratories. Antibodies specific for double phos-
phorylated ERK1/2 or MEK1/2 were purchased from New England
BioLabs, Inc. Anti-His
 
6
 
 and anti-Xpress antibodies were from Invitrogen,
and the anti-CD107a (LAMP-1) antibody was obtained from BD Phar-
Mingen. Polyclonal anti-GST antibodies were generated in the lab.
Alexa 488™, Alexa 568™, Cy3™, and Texas red–labeled secondary anti-
bodies were obtained from Molecular Probes, Amersham Pharmacia
Biotech, and Jackson ImmunoResearch Laboratories, respectively.
LysoTracker™, Red DND-99, and EGF-rhodamine were from Molecular
Probes. Anti-EEA1 (Rubino et al., 2000) and anti-Rab11 (Ullrich et al.,
1996) antibodies were generous gifts from Dr. Marino Zerial (European
Molecular Biology Laboratory, Heidelberg, Germany).
 
Cell Homogenization and Membrane Preparation
 
EpH4 cells were homogenized and postnuclear supernatant (PNS) was
prepared in homogenization buffer (250 mM sucrose, 3 mM imidazole, pH
7.4, 1 mM EDTA, containing a cocktail of protease inhibitors, 10 
 
m
 
g/ml
aprotinin, 1 
 
m
 
g/ml pepstatin, 10 
 
m
 
g/ml leupeptin, and 1 mM Pefabloc solid
compound) (Boehringer) as outlined previously (Gruenberg and Gorvel,
1992; Fialka et al., 1997; Pasquali et al., 1997). Continuous sucrose gradi-
ents were used to separate different membrane compartments as de-
scribed (Fialka et al., 1997). Peripheral membrane proteins were sepa-
rated from integral membrane proteins by extraction with 0.1 M Na
 
2
 
CO
 
3
 
,
pH 11.0 (Fujiki et al., 1982).
 
2DGE and Peptide Sequencing
 
2DGE and microsequencing of protein spots were performed as described
in detail elsewhere (Fialka et al., 1997; Pasquali et al., 1997; Fialka et al.,
1999).
 
Indirect Immunofluorescence
 
EpH4, HeLa, and Caco-2 cells were fixed with 4% paraformaldehyde in
cytoskeleton buffer (10 mM Pipes, pH 6.8, 150 mM NaCl, 5 mM EGTA, 5
mM glucose, 5 mM MgCl
 
2
 
) for at least 30 min, quenched by three washes
with washing buffer (cytoskeleton buffer, 50 mM NH
 
4
 
Cl), and permeabi-
lized with cytoskeleton buffer supplemented with 0.3–0.5% Triton X-100.
Specimens were processed for indirect immunofluorescence, mounted in
Mowiol (Hoechst), and finally viewed using an Axioplan2 microscope
(ZEISS). For confocal microscopy, samples were mounted in 50% glyc-
erol, 4% 
 
n
 
-propyl gallate (Sigma-Aldrich) in cytoskeleton buffer. Confo-
cal images were obtained with a Leica TCS NT confocal microscope and
processed using the Imaris and colocalization software packages (Bitplane
AG) after deconvolution using measured point-spread functions with the
Huygens software (Scientific Volume Imaging).
 
Proteinase K Treatment of PNS
 
Equal volumes of PNS from EpH4 cells (
 
z
 
0.5 
 
m
 
g/
 
m
 
l protein) were treated
with increasing concentrations of proteinase K (0.01–10 
 
m
 
g/ml; GIBCO
BRL) for 20 min at room temperature. The reaction was stopped by addi-
tion of 100 mM PMSF. Undigested membrane material was pelleted at
100,000 
 
g
 
 and proteins were analyzed by immunoblots.
 
Two-Hybrid Screen
 
A two-hybrid screen was performed using the Matchmaker Gal4 Two-
Hybrid System 2 (CLONTECH Laboratories, Inc.) following the manufac-
turer’s screening protocol. Bait constructs were generated by PCR from
the original clone obtained from the United Kingdom Human Genome
Mapping Project Resource Centre (I.M.A.G.E. Consortium CloneID
681056) (Lennon et al., 1996) using primers introducing an EcoRI site
NH
 
2
 
-terminally and a PstI site COOH-terminally of the respective frag- 
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ments and subsequent cloning of these fragments into pAS2-1 (CLON-
TECH Laboratories, Inc.). The resulting chimeric proteins consisted of
the Gal4 DNA binding domain fused in frame to the full length protein,
an NH
 
2
 
-terminal fragment of p14 (amino acids 1–48), or two different
COOH-terminal fragments (C1, amino acids 43–125; and C2, amino acids
80–125). After titration of the appropriate 3-amino-1,2,4-triazole concen-
tration to inhibit background His3 activity, the different bait constructs
were introduced into yeast strain HF7c, tested for autonomous activation,
and subsequently screened for interacting polypeptides using a mouse em-
bryo Matchmaker cDNA library cloned into pACT2 (CLONTECH Labo-
ratories, Inc.). The pAS2-1 C2 construct showed autoactivation resistant
to 3-amino-1,2,4-triazole, and thus was not used for further screening.
 
Constructs and Transfection
 
Tagged versions of p14 and MP1 containing a triple myc tag at the NH
 
2
 
termini of the proteins were constructed by PCR using primers introduc-
ing appropriate restriction sites (p14) or by direct cloning from one of the
positive pACT2 clones (MP1) into a pBluescript SK vector containing
three myc sequences preceded by a Kozak sequence (Kozak, 1999) that
was constructed in our laboratory. The coding sequences of the resulting
chimeric proteins (myc
 
3
 
-p14 and myc
 
3
 
-MP1) were cloned into expression
vectors pREP10 (Invitrogen), resulting in sense or antisense myc
 
3
 
-p14
constructs, and pUB6/V5-His (out of frame of the COOH-terminal V5-
His tag) (Invitrogen), respectively. CAAX-tagged p14 was constructed by
introducing a linker sequence encoding the last 21 amino acids of human
K-ras (Choy et al., 1999) at the COOH terminus of the p14 cDNA, replac-
ing the STOP codon. Both bona fide p14 and p14–CAAX were cloned in
frame with the His
 
6
 
/Xpress-tag into pEF4/HisC (Invitrogen) to give rise to
NH
 
2
 
-terminally tagged X-p14 and X-p14–CAAX expression vectors.
EGFP–p14 was constructed by cloning the coding sequence of p14 into
pEGFP-C1 (CLONTECH Laboratories, Inc.). Cells were transfected with
the different constructs by use of Lipofectamin Plus (GIBCO BRL) fol-
lowing the manufacturer’s suggestions and eventually selected accordingly
for stable transfectants.
Recombinant proteins were constructed in pGEX6P3 (Amersham
Pharmacia Biotech) or pET28 (Novagen).
 
Immunoprecipitation
 
Transfected cells were scraped in PBS and lysed by a combination of a
quick freeze–thaw cycle and sonication. After centrifugation at 1,600 
 
g
 
,
the supernatant was diluted in IP buffer (10 mM Hepes, pH 7.4, 137 mM
NaCl, 4.7 mM KCl, 0.65 mM MgSO
 
4
 
, 1.2 mM CaCl
 
2
 
, 1% Triton X-100, 2
mM NaF, 20 mM 
 
b
 
-glycerophosphate, and protease inhibitors as for cell
homogenization). After preclearing with UltraLink™ immobilized pro-
tein A (Pierce Chemical Co.), the resulting supernatant was subjected to
immunoprecipitation using preimmuneserum or polyclonal anti-myc anti-
bodies and UltraLink™ immobilized protein A or protein A alone as ad-
ditional negative control. After three washes with IP buffer, the samples
were boiled in loading buffer and resolved on SDS-PAGE.
 
Glycerol Density Gradients
 
Total membranes from EpH4 cells were enriched by centrifugation of
PNS at 100,000 
 
g
 
, resuspended in extraction buffer (20 mM Hepes/KOH,
pH 7.0, 100 mM KCl, 1 mM DTT, 1% Triton X-100, 2 mM NaF, 20 mM
 
b
 
-glycerophosphate, and a cocktail of protease inhibitors as above), and
extracted on ice for 30 min. The insoluble material was pelleted at 17,000 
 
g
 
and the resulting supernatant (containing p14 and MP1) was loaded on
top of a continuous glycerol gradient (5–35% in extraction buffer). Gradi-
ents were centrifuged at 270,000 
 
g
 
 overnight in an SW41 rotor (Beckman
Coulter). Then, 600-
 
m
 
l fractions were collected, and proteins were precip-
itated and analyzed by 12.5% SDS-PAGE and immunoblots. For gradient
calibration, we used a protein mix (1 
 
m
 
g/
 
m
 
l BSA, 4.5 S, 2 
 
m
 
g/
 
m
 
l aldolase,
7.3 S, 2 
 
m
 
g/
 
m
 
l catalase, 10.0 S, and 1 
 
m
 
g/
 
m
 
l thyroglobulin, 19.5 S, in homog-
enization buffer) the distribution of which was detected by Coomassie
stain after SDS-PAGE.
 
In Vitro Pull-down Assay
 
Bacterial lysates containing recombinant proteins were prepared by sonica-
tion in PBS. GST and GST fusion proteins were bound to glutathione-
Sepharose (Amersham Pharmacia Biotech), washed with PBS, and incu-
bated with lysates containing His
 
6
 
-tagged recombinant proteins for 20 min
at room temperature. Subsequently, the Sepharose-bound proteins were
washed, resuspended in sample buffer, and analyzed by SDS-PAGE and
immunoblots. Because of the reported promiscuity in the in vitro interac-
 
tion of MP1 with the different isoforms of the kinases (Schaeffer et al.,
1998), we used a GST–ERK2 construct that was obtained from M.J. Weber
(University of Virginia, Charlottesville, VA).
 
Electron Microscopy
 
Caco-2 cells expressing EGFP–p14 were fixed in 4% paraformaldehyde/
0.1% glutaraldehyde in 0.1 M phosphate buffer, pH 7.35, for 1 h at room
temperature. They were then washed with 0.2 M phosphate buffer,
scraped from the culture dish, and pelleted in a microfuge. The cells were
then resuspended in warm gelatin (10% in phosphate buffer) and repel-
leted at maximum speed in the microfuge. After cooling, the gelatin-
embedded cells were infiltrated with polyvinyl pyrrolidone sucrose over-
night at 4
 
8
 
C and then processed for frozen sectioning as described (Liou et
al., 1997). Ultrathin frozen sections (60–80 nm) were labeled, stained, and
viewed (Jeol 1010; Centre for Microscopy and Microanalysis) according to
published techniques (Parton et al., 1997).
 
Online Supplemental Material
 
Caco-2 cells stably expressing EGFP–p14 were grown on coverslips and
observed using a confocal microscope. Video available at http://
www.jcb.org/cgi/content/full/152/4/765/DC1 shows the enlargement of one
of the EGFP–p14 labeled vesicles in Fig. 5, revealing the existence of a
mobile internal vesicle.
 
Results
 
A New Highly Conserved Peripheral Membrane
Protein Enriched in the Late
Endosomal/Lysosomal Compartment
 
To investigate the protein composition of the endocytic
compartment, we applied techniques already successfully
used for the analysis of membrane-associated organelle
proteins within the mammary epithelial cell line EpH4 (Fi-
alka et al., 1997, 1999; Pasquali et al., 1997, 1999). First, we
performed sucrose density gradient centrifugation of PNSs
to separate organelles derived from early and late en-
docytic compartments, respectively. It is important to em-
phasize that continuous sucrose gradients efficiently sepa-
rate very light from dense fractions. In such gradients,
Golgi complex membranes comigrate in fractions of me-
dium density together with plasma membrane (both the
apical and basolateral plasma membrane in epithelial
cells) as well as with early endosomes. However, late en-
dosomes which resemble a similar density as lysosomes
could easily be separated and distinguished from the bulk
of other membranes (Fialka et al., 1997, 1999; Pasquali et
al., 1999). Gradient-enriched organelle fractions were then
applied to high resolution 2DGE to obtain a protein pat-
tern allowing the identification of proteins specifically en-
riched in late endosomal/lysosomal fractions. Since a lot of
proteins described in regulating endocytic transport (for
example, Rab proteins) or scaffolding signal transducing
modules (for example, Ste5p) are peripherally associated
with membranes, we further characterized the fractions by
carbonate extraction at high pH (Fujiki et al., 1982; Pas-
quali et al., 1997).
Fig. 1 A shows the analysis of the sucrose density gradi-
ent with respect to the activity of HRP internalized by
fluid phase endocytosis for different time periods as well
as by Western blotting for established compartment mark-
ers (Rab5 for the early endosome, Rab4, Rab11, and
transferrin receptor for the recycling endosome, and Rab7
for the late endosome) (Bucci et al., 2000; Sonnichsen et
al., 2000). Peak fractions for Rab5/HRP activity at 0 min
chase (fraction 14–16) and Rab7/HRP activity at 20 min 
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chase (fraction 6
 
1
 
7) were used for 2DGE analysis of early
endosomal (Fig. 1 C) and late endosomal (Fig. 1 D) frac-
tions, respectively. The second peak fraction of Rab5
(fraction 18–20) was omitted since it contained the bulk of
plasma membrane and rough ER fractions.
A large number of spots were found to be enriched in
either early or late endosomal fractions (compare Fig. 1,
C and D). In this report, we describe the investigation
of a particular protein spot with an experimental iso-
 
electric point (pI) of 
 
z
 
5.0 and a molecular mass of 
 
z
 
14
kD in more detail (arrow, inset in Fig. 1, B–D). It was
abundant and enriched in gradient-purified organelle
fractions containing mainly late endosomes and lyso-
somes when compared with PNS or early endosome–
containing fractions (Fig. 1, B–D). In addition, this pro-
tein was exclusively associated with membrane fractions
of that density and never detected in the cytoplasmic
fractions.
Figure 1. Subcellular fractionation and analysis
of endosomal compartments. (A) HRP was in-
ternalized into polarized EpH4 cells for 5 min.
Cells were either kept on ice (0 min chase) or in-
cubated for another 20 min at 378C (20 min
chase). Cells were scraped, homogenized, and
PNS was prepared. PNS was loaded on top of
continuous sucrose gradients and separated by
centrifugation as outlined in Materials and
Methods. Fractions were collected, and HRP ac-
tivity was measured (top) and immunoblotted
for Rab4, Rab5, Rab7, Rab11, and transferrin
receptor (bottom). (B–D) PNS, fractions 617
(LE), and fractions 18119 (EE) were analyzed
by 2DGE and compared according to enrich-
ment of protein spots in EE and LE versus PNS,
respectively. Insets show the region containing a
protein (arrow) with experimental Mr z 14 kD
and pI z 4.9, specifically enriched in LE.
Figure 2. Sequences of p14
in multicellular organisms.
Comparison of conceptual
translations of EST se-
quences from a variety of
taxons. 
Wunderlich et al. 
 
The p14–MP1 Complex: A Late Endocytic MAPK Scaffold?
 
769
 
The spot was excised from a preparative gel (Pasquali et
al., 1997), digested, and microsequenced by Edman degra-
dation. Two peptide sequences were obtained: KETV-
GFGMLK and KAQALVQYLEEPLTQVA. These se-
quences were found to be part of open reading frames
from several EST clones, originating from a variety of dif-
ferent species, organs, developmental stages, and cell
lines. Comparison of the primary polypeptide sequences
of different species revealed very high sequence conserva-
tion within multicellular organisms (Fig. 2). However, we
did not detect a sequence with significant homology in the
yeast genome. Comparison with databases of known pro-
teins did not reveal homology to any other existing protein
or protein domain. The calculated pI (5.3) and molecular
mass (13,480 D) of the mouse protein, now termed p14,
corresponded well with the experimental data obtained
from our two-dimensional gels (see above; mouse se-
quence data for p14 are available from GenBank/EMBL/
DDBJ under accession no. AJ277386). On the transcrip-
tional level, we were able to detect a single RNA of 700 bp
in EpH4 cells. We could show ubiquitous expression on a
multiple tissue Northern blot from CLONTECH Labora-
tories, Inc. (data not shown).
In a secondary analysis, we investigated the membrane
topology of p14. The protein displayed features of a pe-
ripheral membrane protein since it was partially extract-
able by carbonate at high pH (Fig. 3 A). Furthermore, we
prepared PNSs under conditions that maintain the integ-
rity of vesicles and subjected them to proteinase K diges-
tion. Proteinase K is not membrane permeable and thus,
digests at limited concentrations only proteins accessible
at the cytoplasmic face of membranes. Under these condi-
tions, p14 was much more sensitive to digestion than
known lumenal marker proteins, such as calreticulin
Figure 3. Membrane topology of p14. (A) PNS from polarized
EpH4 cells was loaded on top of a continuous sucrose gradient
and sedimented organelle fractions enriched in p14 were ex-
tracted with Na2CO3, pH 11.0. Input (left), carbonate insoluble
(middle), and carbonate soluble (right) proteins were analyzed
by 2DGE. Respective areas of high resolution two-dimensional
gels are shown; arrows indicate p14. (B) PNS from polarized
EpH4 cells was treated with increasing concentrations of protein-
ase K. Digested samples were analyzed by immunoblot, quanti-
fied, and the percentage of intact protein compared with undi-
gested controls was plotted (numbers are an average of three
independent experiments 6 SD). A lumenal protein (calreticu-
lin) and Rab5 as a protein associated with the cytoplasmic leaflet
of membranes were taken as controls.
Figure 4. Subcellular localization of p14. EpH4 cells, transiently
transfected with EGFP-p14 (A9), were treated with Lyso-
Tracker™. (A) Living cells were observed under a confocal mi-
croscope. Caco-2 cells, stably transfected with EGFP-p14 (B9),
were fixed and coimmunolocalization with LAMP-1 was per-
formed (B). Merged images in A99 and B99. Bars, 10 mm. 
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(Krause and Michalak, 1997), or even proteins on the cy-
toplasmic side, such as Rab5 (Somsel Rodman and Wan-
dinger-Ness, 2000) (Fig. 3 B). Calreticulin was chosen since
it represented a well-characterized lumenal marker pro-
tein of the ER, the most abundant vesicle fraction in PNSs.
Taken together, these results suggested a peripheral asso-
ciation of p14 with the cytoplasmic face of membranes.
To confirm the subcellular localization of p14, we ex-
pressed an EGFP-tagged version of p14 in EpH4 cells and
incubated the cells with LysoTracker™ Red DND-99, an
acidotropic probe. Live microscopy revealed vesicular
structures surrounded by the green fluorescence of
EGFP–p14 and filled with the red fluorescence of the
lysotracker (Fig. 4, A, A
 
9
 
, and A
 
99
 
), indicating a localiza-
tion of p14 on acidic organelles such as late endosomes
and lysosomes. To exclude mistargeting mediated by the
EGFP tag or by overexpression, the analysis was extended
with differently tagged versions of p14 in two other cell
types (Caco-2 and HeLa) (data not shown). Another epi-
thelial cell line, Caco-2 cells stably expressing EGFP–p14,
was used for coimmunofluorescence with LAMP-1, a
transmembrane glycoprotein localizing mainly to late en-
dosomes/lysosomes. In these cells, LAMP-1 showed a
complete overlap with the exogenously expressed p14
(Fig. 4, B, B
 
9
 
, and B
 
99
 
). This result was further confirmed
by exploiting the well-studied intracellular trafficking of
the EGFR and its ligand. After binding to the EGFR at
the cell surface, EGF gets internalized together with its re-
ceptor and is transported to the early then to the late en-
docytic compartment and finally destined to degradation
in lysosomes (Sorkin et al., 1988). EpH4 cells transiently
transfected with EGFP–p14 were allowed to internalize
EGF-rhodamine for various times and were then ob-
served live under a microscope. EGF, initially separated
from the green fluorescence (Fig. 5; 0, 5, and 10 min
chase), was subsequently filling the compartment labeled
with EGFP (Fig. 5; 24 h chase), confirming the association
of p14 with late endosomes/lysosomes in living cells. In
addition, HeLa cells stably transfected with EGFP–p14
were analyzed in coimmunolocalization experiments with
early endocytic marker proteins. Neither EEA1 (Fig. 6, A,
A
 
9
 
, and A
 
99
 
), involved in vesicular transport from the
plasma membrane to the early endosomes (Rubino et al.,
2000), or Rab11 (Fig. 6, B, B
 
9
 
, and B
 
99
 
), which regulates
recycling through the pericentriolar recycling endosome
(Ullrich et al., 1996), showed any significant coimmunolo-
calization with p14.
Immunoelectron microscopy confirmed and extended
these observations. The majority of the labeling for the
EGFP-tagged protein was associated with large elec-
tron-lucent structures with internal vesicular or lamellar
membranes that were labeled with antibodies to the late
endosomal marker, lysobisphosphatidic acid (LBPA)
(Fig. 7). As shown previously (Kobayashi et al., 1998),
the LBPA antibody labeled the internal membranes of
the late endosomes. In contrast, EGFP–p14 was pre-
dominantly, although not exclusively (see video at http://
www.jcb.org/cgi/content/full/152/4/765/DC1), associated
with the cytoplasmic surface of the late endosomes. In
addition, EGFP–p14 labeling was associated with puta-
Figure 5. Internalized EGF-rhodamine meets
p14 in a late endocytic compartment. EGF-
rhodamine was internalized for 5 min, 10 min,
and 24 h in EpH4 cells transiently transfected
with EGFP–p14. Before internalization at 378C,
EGF-rhodamine was bound to the cell surface
for 1 h at 48C. Living cells were observed under a
confocal microscope. After 24 h internalization,
the EGFP-p14–containing compartment was
filled with EGF-rhodamine. Video available at
http://www.jcb.org/cgi/content/full/152/4/765/DC1.
Bars, 10 mm. 
Wunderlich et al. 
 
The p14–MP1 Complex: A Late Endocytic MAPK Scaffold?
 
771
 
tive lysosomal structures with an electron-dense core
and negligible LBPA labeling (for example, Fig. 7 C).
Smaller spherical LBPA-negative multivesicular endo-
somal structures, morphologically identifiable as endo-
some carrier vesicles (Clague et al., 1994), also showed
low but specific labeling with the anti-GFP antibody
(Fig. 7 C). Taken together, we conclude that this novel
peripheral membrane protein localizes to the cytoplas-
mic face of late endosomal and lysosomal compart-
ments in several different cell types and species.
 
Interaction of p14 with MP1
 
To investigate the biological function of p14, we attempted
to identify potential interaction partners of p14. There-
fore, we performed two-hybrid screens using different
parts of the p14 coding sequence (full length, an NH
 
2
 
-ter-
minal, and a COOH-terminal fragment) as bait fused to
the Gal4 DNA binding domain. With each construct, we
screened 1.2–5.6 
 
3
 
 10
 
5
 
 independent clones of a mouse em-
bryonic library (Table I). Among positive clones, several
contained the complete coding region of MP1, a protein
recently identified as a scaffold protein of the MAPK
pathway (Schaeffer et al., 1998). We obtained interacting
MP1 clones with all three different bait constructs (Table
I), suggesting that different parts of the relatively small
p14 protein were involved in the interaction with MP1. Al-
ternatively, the small overlap of the NH
 
2
 
- and COOH-ter-
minal constructs (see Materials and Methods) may play a
central role in the interaction with MP1.
The interaction between p14 and MP1 was further con-
firmed with a variety of methods. First, the direct interac-
tion between these two proteins was tested in a GST pull-
down assay. GST-tagged p14 was able to directly interact
with His
 
6
 
-T7-MP1 (Fig. 8, lane 2). The specificity of this in-
teraction was shown by the failure of His
 
6
 
-T7–tagged MP1
to interact with GST alone (Fig. 8, lanes 3 and 4) and by
the ability of excess His
 
6
 
-tagged p14 to abrogate the GST–
p14/His
 
6
 
-T7-MP1 interaction (Fig. 8, lane 1). In addition,
His
 
6
 
-tagged p14 weakly bound to GST–p14 (Fig. 8, lane 1),
raising the possibility of a self-association.
The direct interaction in the yeast two-hybrid assay and
in pull-down assays in vitro demonstrated the ability of the
two proteins to form a complex. Next, we tested if this
complex could also form in vivo. For this purpose, we con-
structed HeLa cells expressing myc-tagged versions of p14
or MP1 and performed immunoprecipitations with anti-
myc antibodies. In these experiments, endogenous MP1
was detectable in immunoprecipitations of myc-p14 and
endogenous p14 in immunoprecipitations of myc-MP1
(Fig. 9 A), demonstrating an in vivo
 
 
 
interaction of p14 and
MP1. To further analyze a possible complex of p14–MP1
proteins, we separated proteins and protein complexes af-
ter detergent extraction of a 100,000-
 
g
 
 PNS pellet from
EpH4 cells on continuous glycerol gradients. Herein, en-
dogenous p14 and MP1 cofractionated with a similar sedi-
mentation coefficient of 
 
z
 
5–6 S (Fig. 9 B).
Further support for a complex formation between p14
and MP1 in vivo came from colocalization experiments. In
HeLa cells overexpressing Xpress-tagged p14 and myc-
tagged MP1, both proteins localized to the same perinu-
clear, LAMP-1–positive compartment (Fig. 10). In addi-
tion, fusing Xpress-tagged p14 to the hypervariable
domain and CAAX motif of K-Ras (Choy et al., 1999),
leading to plasma membrane localization of p14, resulted
Figure 6. p14 does not colocalize with early endocytic markers.
HeLa cells, stably transfected with EGFP–p14 (A9 and B9), were
fixed and coimmunolocalization with EEA1 (A) and Rab11 (B)
was performed. Merged images in A99and B99. Bars, 10 mm.
Table I. Summary of Two-Hybrid Screen for p14 Interaction Partners
Bait Screened clones Positive clones Typical false positive MP1
Gal4-wt 1.2 3 105 24 2 15
Gal4-N 4.8 3 105 50 1
Gal4-Cl 5.6 3 105 53 1The Journal of Cell Biology, Volume 152, 2001 772
in efficient recruitment of coexpressed MP1 to the same
sites (Fig. 10, bottom).
Recruitment of MAPK Cascade Components to the 
p14–MP1 Complex
MP1 was identified as a complex partner for MEK1 and
ERK1 in vivo as well as ERK2 in vitro (Schaeffer et al.,
1998). This prompted us to try to reconstitute in vitro com-
plexes and to analyze complexes from cells for all of these
components.
For the in vitro reconstitution, bacterially expressed
GST-tagged ERK2 was used to pull down His6-p14, His6-
T7-MP1, and His6-T7-MEK1. In this experimental setup,
we failed to detect a direct interaction of MEK1 with
MP1 in vitro (data not shown). The previously published
Figure 7. Immunoelectron
microscopic localization of
p14. Caco-2 cells, stably
transfected with EGFP–p14,
were fixed and processed for
frozen sectioning. Sections
were double labeled for p14
(detected with 15 nm-gold-
labeled goat anti–rabbit
antibodies) and LBPA (de-
tected with 10 nm gold-
labeled goat anti–mouse an-
tibodies). Specific labeling
for EGFP–p14 (large gold;
arrows in B–D) is associated
with large multivesicular and
multilamellar late endo-
somes which are labeled for
LBPA (arrowheads, all pan-
els). Labeling for EGFP–p14
is predominantly around the
periphery of the late endo-
somes with lower labeling as-
sociated with LBPA-positive
internal membranes. In C, in
addition to labeling of late
endosomes, lower but spe-
cific labeling is associated
with putative lysosomes
which are electron dense and
LBPA-negative (L) and with
putative endosome carrier
vesicles (E). Bars: (A and B)
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MEK1–MP1 interaction (Schaeffer et al., 1998) has been
obtained using proteins produced with the baculovirus ex-
pression system. Therefore, the apparent difference might
be explained by the source of recombinant MP1. How-
ever, His6-T7-MP1 efficiently bound to GST–ERK2 (Fig.
8, lane 5), and this interaction was not abrogated by excess
His-tagged p14. Instead, p14 bound to GST–ERK2 in ad-
dition to MP1 (Fig. 8, lane 6).
Surprisingly, our coimmunoprecipitation experiments
from cell extracts had contrary results. Although we could
coimmunoprecipitate HA-tagged MEK1 together with
p14 and MP1 (Fig. 11), we did not succeed in recruiting
Flag-tagged ERK1 to the p14–MP1–MEK1 complex (data
not shown).
Interestingly, using untransfected cells we found double
phosphorylated ERK1/2 cosedimenting with p14 and MP1
in glycerol gradients (Fig. 9 B) but not activated MEK1/2
(data not shown).
Taken together, the late endosomal/lysosomal periph-
eral membrane protein, p14, specifically interacted with
MP1 and members of the MAPK cascade. However, in
contrast to the constitutive interaction between p14 and
MP1, MEK1 and ERK1 associate with this complex in a
regulated or more dynamic fashion.
Discussion
The MAPK/ERK pathway is a ubiquitously expressed sig-
naling module in vertebrate and invertebrate organisms
which governs the proliferation, differentiation, and sur-
vival of cells. The basic setup of this pathway is a cascade
of three kinases, Raf®MEK®MAPK/ERK, that sequen-
tially activate each other and several associated proteins
that modulate signal transduction. The Raf family of
MAPK kinase kinases (consisting of three known mem-
bers, A-Raf, B-Raf, and c-Raf) is thought to integrate up-
stream input signals into this biochemical signaling mod-
ule. Besides other targets (Pearson et al., 2000), members
of the Raf family activate the MAPK kinases MEK1 or
MEK2 by dual phosphorylation. And finally, the ERK
family of MAP kinases, ERK1 and ERK2 being the only
known substrates of MEK, are considered the effector end
with an impressive roster of .50 substrates described to
date (Garrington and Johnson, 1999).
To achieve an appropriate physiological response, the
cell has to generate specificity within the cascade and also
at its effector end. Using signaling scaffolds and intracellu-
lar membrane transport, the cell recruits several different
signaling molecules of a given cascade into a multiprotein
complex (Pawson and Scott, 1997; Elion, 1998; Zuker and
Ranganathan, 1999) while excluding others (Haugh et al.,
1999a,b). Absence or mutation of scaffolds (Liao and
Thorner, 1980; Inouye et al., 1997) as well as irregular in-
tracellular trafficking (Kranenburg et al., 1999; York et al.,
2000; Zhang et al., 2000) results in functional incompe-
tence of the cell to respond properly to signals.
In this report, we described our efforts in searching for
and analyzing the composition of organelle fractions
highly enriched in early or late endosomes/lysosomes, re-
spectively, using a targeted proteomic approach. One of
the proteins enriched on late endosomes/lysosomes was
identified to be a novel, highly conserved protein. We
demonstrated that this protein, which we termed p14, is
peripherally associated with the cytoplasmic face of late
endosomes/lysosomes.
In search of the molecular environment of this protein,
we isolated the MAPK scaffold MP1 (Schaeffer et al.,
1998) as interaction partner in a two-hybrid screen. We
confirmed this interaction by GST pull-down assays, co-
fractionation, coimmunoprecipitation, colocalization, and
comislocalization experiments.
The interaction between p14 and MP1 raised the possi-
bility that MAPK kinase signaling is modulated by p14
since MP1 has been shown to specifically enhance the acti-
Figure 8. Interaction between p14 and MP1 in vitro. Recombi-
nant GST-tagged p14 (lanes 1 and 2), GST (lanes 3 and 4), or
GST–ERK2 (lanes 5 and 6) was incubated with recombinant
His6-T7–tagged MP1 alone (lanes 2, 3, and 5) or with additional
His6-tagged p14 (lanes 1, 4, and 6). Amounts of GST proteins are
illustrated in the bottom panel by Ponceau staining.
Figure 9. Interaction between p14 and MP1 in vivo I: coimmuno-
precipitation and cosedimentation. (A) Extracts from HeLa cells
stably transfected with myc3-p14 or a reverse myc3-p14 construct
as control were subjected to immunoprecipitation using poly-
clonal anti-myc antibodies. 50% of the extracts from the reverse
control (rev) or myc3-p14 expressing cells (p14) were analyzed as
input controls. Immobilized protein A alone (PA) or with preim-
mune serum (PI) was used to control for unspecific binding.
Coimmunoprecipitated MP1 was analyzed by immunoblotting.
(B) Extracts from HeLa cells stably expressing myc3-MP1 were
analyzed for coimmunoprecipitation of p14 as in A. 20% of the
extract was loaded as input control. (C) Total membranes of
EpH4 cells were enriched by centrifugation at 100,000 g. Ex-
tracted proteins were loaded onto a 5–35% glycerol gradient and
collected fractions were analyzed by immunoblotting. S values of
a mix of known proteins are indicated.The Journal of Cell Biology, Volume 152, 2001 774
vation of ERK1 by MEK1 (Schaeffer et al., 1998). There-
fore, we tested if MEK or ERK recruitment to MP1 is dis-
turbed or enhanced by p14. These experiments clearly
demonstrated that it is possible to reconstitute complexes
that contain a member of the MAPK module together
with MP1 and p14 in vitro and in vivo, indicating that p14
does not disturb the direct interaction of MP1 with the
MAPK module. The difficulty of these experiments is that
scaffolding activity is not constitutive but always con-
nected to a specific biological context. Therefore, for a re-
ally meaningful interpretation of assays investigating the
effect of p14 on MAPK signaling, we will first have to de-
fine the upstream signal that uses the p14–MP1 complex to
achieve its proper physiological response before further
exploring a possible modulating activity of p14 per se.
Connected to the question of the putative involvement of
p14 in regulating MAPK signaling is the question of
whether the p14–MP1 interaction is regulated. Our results
indicated that binding of these two proteins to each other
is constitutive because the interaction occurs in vitro with
bacterially expressed proteins. However, disassembly could
be an induced process, but again we will have to address
this issue in future studies within the connected biological
context.
The localization of the p14–MP1 complex on late endo-
somes/lysosomes suggests a function connected to this com-
partment. Lysosomes have mostly been considered to be
the digestive organelles of the cell. In this context, a modu-
lation of membrane transport towards lysosomes and/or
back to the late endosomal compartment could be the tar-
get of a MAPK scaffolding activity, thereby connecting reg-
ulation of membrane transport and MAPK signaling.
On the other hand, there is evidence for other functions
of the lysosome because this organelle is able to fuse with
the plasma membrane (Andrews, 2000). Although the role
of this process is not yet clear for nonhematopoetic cells, it
seems clear that is has to be tightly regulated. There is evi-
dence from hematopoetic cells that extracellular signal–
regulated kinases are involved in exocytosis of a lysosome-
related organelle, the secretory granule (Trotta et al.,
1998; Johnson et al., 1999), suggesting that lysosomal
MAPK scaffolding could be involved in regulating lysoso-
mal secretion.
In summary, our discovery bears the potential of com-
bining scaffolding and intracellular membrane transport as
means to control the specificity in MAPK signaling in the
sense of the p14–MP1 complex being a MAPK scaffold lo-
calizing to the late endosomal/lysosomal compartment.
Figure 10. Interaction between p14 and MP1 in vivo II:
colocalization and comislocalization. HeLa cells were
transiently cotransfected with X-p14 (top and middle
panel) or X-p14–CAAX (bottom panel) and MP1-myc6.
After 24 h incubation, the cells were fixed and processed
for indirect immunofluorescence using anti–LAMP-1,
anti-Xpress and anti-myc antibodies. Bars, 10 mm.
Figure 11. Recruitment of MEK1 to the p14–MP1 complex. Ex-
tracts from HeLa cells transiently transfected with HA-MEK1
together with X-p14 or MP1-myc6 or both were subjected to im-
munoprecipitation using polyclonal anti-myc antibodies. Input
and immunoprecipitates were used for immunoblot analysis us-
ing anti-HA, anti-myc, and anti-Xpress antibodies.Wunderlich et al. The p14–MP1 Complex: A Late Endocytic MAPK Scaffold? 775
This would connect the concepts of catalytic scaffolds
mainly described for the regulation of the MAPK path-
way, and anchoring scaffolds, a mechanism already de-
scribed for another signaling pathway, the protein kinase
A (PKA) pathway. Herein, PKA is very locally activated
by so-called A kinase anchoring proteins (AKAPs). These
proteins are interacting with the regulatory (R) subunit of
PKA at the same time as they are targeted to specific sub-
cellular locations, thereby mediating compartmentaliza-
tion of PKA activity (Faux and Scott, 1996; Edwards and
Scott, 2000).
However, we cannot yet exclude the possibility that the
p14–MP1 complex, or one of the two, could be seques-
tered onto the late endosomal/lysosomal compartment.
This sequestration could be released upon a signal that ac-
tivates effector pathways that need MP1 to achieve their
specificity.
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